Trevi Therapeutics, Inc is a biotechnology business based in the US. Trevi Therapeutics shares (TRVI) are listed on the NASDAQ and all prices are listed in US Dollars. Trevi Therapeutics employs 23 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Trevi Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TRVI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Trevi Therapeutics stock price (NASDAQ: TRVI)Use our graph to track the performance of TRVI stocks over time.
Trevi Therapeutics shares at a glance
|Latest market close||$2.05|
|52-week range||$1.78 - $6.73|
|50-day moving average||$2.13|
|200-day moving average||$2.53|
|Wall St. target price||$11.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-9.14|
Buy Trevi Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Trevi Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Trevi Therapeutics price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-6.39%|
|3 months (2021-04-26)||-14.23%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Trevi Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-41.12%|
|Return on equity TTM||-92.66%|
|Market capitalisation||$43.8 million|
TTM: trailing 12 months
Shorting Trevi Therapeutics shares
There are currently 86,330 Trevi Therapeutics shares held short by investors – that's known as Trevi Therapeutics's "short interest". This figure is 1.9% down from 87,982 last month.
There are a few different ways that this level of interest in shorting Trevi Therapeutics shares can be evaluated.
Trevi Therapeutics's "short interest ratio" (SIR)
Trevi Therapeutics's "short interest ratio" (SIR) is the quantity of Trevi Therapeutics shares currently shorted divided by the average quantity of Trevi Therapeutics shares traded daily (recently around 119902.77777778). Trevi Therapeutics's SIR currently stands at 0.72. In other words for every 100,000 Trevi Therapeutics shares traded daily on the market, roughly 720 shares are currently held short.
However Trevi Therapeutics's short interest can also be evaluated against the total number of Trevi Therapeutics shares, or, against the total number of tradable Trevi Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Trevi Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Trevi Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0123% of the tradable shares (for every 100,000 tradable Trevi Therapeutics shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Trevi Therapeutics.
Find out more about how you can short Trevi Therapeutics stock.
Trevi Therapeutics share dividends
We're not expecting Trevi Therapeutics to pay a dividend over the next 12 months.
Trevi Therapeutics share price volatility
Over the last 12 months, Trevi Therapeutics's shares have ranged in value from as little as $1.78 up to $6.727. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trevi Therapeutics's is -0.0785. This would suggest that Trevi Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Trevi Therapeutics has bucked the trend.
Trevi Therapeutics overview
Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, which is in Phase IIb/III clinical trial is an oral extended release formulation of nalbuphine that is used for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease, as well as to treat chronic kidney disease-associated with pruritus. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation; and Rutgers to develop and commercialize products incorporating nalbuphine for any human or animal use. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut. .
Trevi Therapeutics in the news
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Stocks That Hit 52-Week Lows On Thursday
Trevi Therapeutics files to sell 5.17M shares of common stock for holders
Frequently asked questionsWhat percentage of Trevi Therapeutics is owned by insiders or institutions?
Currently 3.653% of Trevi Therapeutics shares are held by insiders and 66.281% by institutions. How many people work for Trevi Therapeutics?
Latest data suggests 23 work at Trevi Therapeutics. When does the fiscal year end for Trevi Therapeutics?
Trevi Therapeutics's fiscal year ends in December. Where is Trevi Therapeutics based?
Trevi Therapeutics's address is: 195 Church Street, New Haven, CT, United States, 06510 What is Trevi Therapeutics's ISIN number?
Trevi Therapeutics's international securities identification number is: US89532M1018
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert